These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6785813)

  • 1. Clozapine: plasma levels and prolactin response.
    Kane JM; Cooper TB; Sachar EJ; Halpern FS; Bailine S
    Psychopharmacology (Berl); 1981; 73(2):184-7. PubMed ID: 6785813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clozapine on human serum prolactin levels.
    Meltzer HY; Goode DJ; Schyve PM; Young M; Fang VS
    Am J Psychiatry; 1979 Dec; 136(12):1550-5. PubMed ID: 507205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia.
    Nair NP; Lal S; Cervantes P; Yassa R; Guyda H
    Neuropsychobiology; 1979; 5(3):136-42. PubMed ID: 431802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine evidence that clozapine's serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptoms.
    Jones H; Curtis VA; Wright P; Lucey JV
    Am J Psychiatry; 1998 Jun; 155(6):838-40. PubMed ID: 9619161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cimetidine-induced increase in prolactin secretion in schizophrenia: effect of clozapine.
    Meltzer HY; Maes M; Lee MA
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S95-104. PubMed ID: 7831446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of response to clozapine.
    Lieberman JA; Kane JM; Safferman AZ; Pollack S; Howard A; Szymanski S; Masiar SJ; Kronig MH; Cooper T; Novacenko H
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():126-8. PubMed ID: 7961556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melperone and clozapine: neuroendocrine effects of atypical neuroleptic drugs.
    Meltzer HY; Koenig JI; Nash JF; Gudelsky GA
    Acta Psychiatr Scand Suppl; 1989; 352():24-9. PubMed ID: 2573238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine.
    Alfaro CL; Wudarsky M; Nicolson R; Gochman P; Sporn A; Lenane M; Rapoport JL
    J Child Adolesc Psychopharmacol; 2002; 12(2):83-91. PubMed ID: 12188977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection.
    Bondesson U; Lindström LH
    Psychopharmacology (Berl); 1988; 95(4):472-5. PubMed ID: 3145517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine plasma levels and convulsions.
    Simpson GM; Cooper TA
    Am J Psychiatry; 1978 Jan; 135(1):99-100. PubMed ID: 412427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine increases rat serum prolactin levels.
    Meltzer HY; Daniels S; Fang VS
    Life Sci; 1975 Aug; 17(3):339-42. PubMed ID: 1160505
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dopamine D4-receptor variants, schizophrenia and clozapine therapy].
    Ewald HL; Mors NP; Rosenberg R
    Ugeskr Laeger; 1996 Jun; 158(25):3601-3. PubMed ID: 8693618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G; Landvogt C; Vernaleken I; Buchholz HG; Ondracek J; Siessmeier T; Härtter S; Schreckenberger M; Stoeter P; Hiemke C; Rösch F; Wong DF; Bartenstein P
    Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
    Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible individual and gender differences in the small increases in plasma prolactin levels seen during clozapine treatment.
    de Leon J; Diaz FJ; Josiassen RC; Simpson GM
    Eur Arch Psychiatry Clin Neurosci; 2004 Oct; 254(5):318-25. PubMed ID: 15365707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making sense of norclozapine levels: 3 clinical axioms.
    Meyer JM
    Schizophr Res; 2024 Jun; 268():289-292. PubMed ID: 37945386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of the evidence of clozapine's anti-aggressive effects.
    Frogley C; Taylor D; Dickens G; Picchioni M
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1351-71. PubMed ID: 22339930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine.
    Rao PA; Pickar D; Gejman PV; Ram A; Gershon ES; Gelernter J
    Arch Gen Psychiatry; 1994 Nov; 51(11):912-7. PubMed ID: 7944879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients.
    Pickar D; Su TP; Weinberger DR; Coppola R; Malhotra AK; Knable MB; Lee KS; Gorey J; Bartko JJ; Breier A; Hsiao J
    Am J Psychiatry; 1996 Dec; 153(12):1571-8. PubMed ID: 8942453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.